{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-000413","form_type":"8-K","ticker":"DMRA","cik":"0001800315","company_name":"Damora Therapeutics, Inc.","filed_at":"2022-01-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.271737+00:00","generated_at":"2026-06-27T20:41:06.354421+00:00","sec_items":[],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Galecto files updated corporate presentation for January 2022 investor meetings","bullets":["Presentation titled 'First-in-class small-molecule anti-fibrotic and anti-cancer agents'.","Filed under Regulation FD; presentation dated January 2022.","No specific new financial or pipeline details disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-000413","json":"https://secwatch.observer/filing/0001564590-22-000413.json","markdown":"https://secwatch.observer/filing/0001564590-22-000413.md","text":"https://secwatch.observer/filing/0001564590-22-000413.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800315/000156459022000413/0001564590-22-000413-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800315/000156459022000413/glto-8k_20220105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T20:41:06.354421+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}